MACERICH CO
8-K, 1998-12-14
REAL ESTATE INVESTMENT TRUSTS
Previous: ULTIMATE ELECTRONICS INC, 10-Q, 1998-12-14
Next: GART SPORTS CO, 10-Q, 1998-12-14



<PAGE>

                         SECURITIES AND EXCHANGE COMMISSION
                                          
                               WASHINGTON, DC  20549
                                          
                                      FORM 8-K
                                          
                                   CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES AND EXCHANGE ACT OF 1934



Date of report (Date of earliest event reported)            December 9, 1998



                                THE MACERICH COMPANY
                 --------------------------------------------------
                 (Exact name of registrant as specified in charter)



          Maryland                     1-12504                95-4448705
- --------------------------------------------------------------------------------
 (State or Other Jurisdiction  (Commission File Number)       (IRS Employer
       of Incorporation)                                   Identification No.)

                                          
          401 Wilshire Boulevard, Suite 700, Santa Monica, CA 90401
- --------------------------------------------------------------------------------
           (Address of principal executive of offices)     (Zip code)




Registrant's telephone number including area code: (310) 394-6911

                                Not applicable.
- --------------------------------------------------------------------------------
           (Former name or former address, if changed since last report)


                                       1
<PAGE>

Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits

(c)  Exhibits


      1.1      Underwriting Agreement, dated December 9, 1998, among Morgan
               Stanley & Co. Incorporated and A.G. Edwards & Sons, Inc. and the
               Registrant regarding the sale of 1,400,000 shares of the
               Registrant's common stock (the "Shares").

      5.1      Opinion of O'Melveny & Myers LLP as to the validity of the
               Shares.

     23.1      Consent of O'Melveny & Myers LLP (included in Exhibit 5.1). 





                                       2
<PAGE>

          Pursuant to the requirements of the Securities and Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized, in the City of Santa Monica, State
of California.

                                       THE MACERICH COMPANY

                                       /s/ Richard A. Bayer
                                      -------------------------------
                                       Richard A. Bayer
                                       General Counsel & Secretary

DATED:    December 14, 1998






                                       3


<PAGE>

                               1,400,000 SHARES

                             THE MACERICH COMPANY

                                 COMMON STOCK

                            UNDERWRITING AGREEMENT

                                                                December 9, 1998

MORGAN STANLEY & CO. INCORPORATED
A.G. EDWARDS & SONS, INC.
c/o Morgan Stanley & Co. Incorporated
    1585 Broadway
    New York, New York 10036

Dear Sirs:

The Macerich Company, a Maryland corporation (the "Company"), proposes to issue
and sell to the several Underwriters named in Schedule I hereto (the
"Underwriters") 1,400,000 shares of its common stock, par value $.01 per share
(the "Firm Shares").  The Company also proposes to issue and sell to the several
Underwriters not more than an additional 210,000 shares of its common stock, par
value $.01 per share (the "Additional Shares"), if and to the extent that you,
as Managers of the offering, shall have determined to exercise, on behalf of the
Underwriters, the right to purchase such shares of common stock granted to the
Underwriters in Section 2 hereof.  The Firm Shares and the Additional Shares are
hereinafter collectively referred to as the "Shares."  The shares of common
stock, par value $.01 per share, of the Company to be outstanding after giving
effect to the sales contemplated hereby are hereinafter referred to as the
"Common Stock."

As used herein, the term "Properties" refers to the properties listed on
Schedule II hereto which represent, as of the date hereof, all the real property
in which the Company, either directly or through its Subsidiaries (as defined
herein) or through ownership of interests in any Joint Venture (as defined
herein), owns an interest.

The Company wishes to confirm as follows its agreement with the Underwriters in
connection with the purchase of the Shares by the Underwriters.

1.   REGISTRATION STATEMENT AND PROSPECTUS.  The Company has prepared and 
filed with the Securities and Exchange Commission (the "Commission") in 
conformity in all material respects with the provisions of the Securities Act 
of 1933, as amended, and the rules and regulations (the "Rules and 
Regulations") of the Commission thereunder (collectively, the "Act"), a 
registration statement on Form S-3 (Registration No. 333-21157) under the Act 
(the "registration statement"), including a prospectus relating to the 
Shares; and an amendment thereto has been filed with the Commission, 

<PAGE>

and such amendment has been similarly prepared.  Such registration statement 
and such amendment have become effective under the Act.  The Company also has 
filed, or proposes to file, with the Commission pursuant to Rule 424(b) under 
the Act, a prospectus supplement relating to the offering of the Shares 
pursuant to Rule 415 of the Act.

The term "Registration Statement" as used in this Agreement means the 
registration statement (including all financial schedules and exhibits), as 
amended at the time it became effective, as supplemented or amended prior to 
the execution of this Agreement.  The term "Prospectus" as used in this 
Agreement means the prospectus in the form first used to confirm sales of 
Shares (the "Base Prospectus") together with the prospectus supplement 
relating to the offering of the Shares under Rule 415 of the Act dated the 
date hereof in the form first filed with the Commission on or after the date 
hereof (the "Prospectus Supplement").  The term "Prepricing Prospectus 
Supplement" as used in this Agreement means the Base Prospectus together with 
any prospectus supplement subject to completion included in the registration 
statement as filed with the Commission pursuant to Rule 424(b) under the Act; 
and as such prospectus shall have been amended from time to time prior to the 
date of the Prospectus.  Any reference in this Agreement to the registration 
statement, the Registration Statement, the Base Prospectus, any Prepricing 
Prospectus Supplement or the Prospectus shall be deemed to refer to and 
include the documents incorporated by reference therein pursuant to Item 12 
of Form S-3 under the Act, as of the date of the registration statement, the 
Registration Statement, such Prepricing Prospectus Supplement or the 
Prospectus, as the case may be, and any reference to any amendment or 
supplement to the registration statement, the Registration Statement, any 
Prepricing Prospectus Supplement or the Prospectus shall be deemed to refer 
to and include any documents filed after such date under the Securities 
Exchange Act of 1934, as amended (the "Exchange Act") which, upon filing, are 
incorporated by reference therein, as required by paragraph (b) of Item 12 of 
Form S-3.  As used herein, the term "Incorporated Documents" means the 
documents which at the time are incorporated by reference in the registration 
statement, the Registration Statement, any Prepricing Prospectus Supplement, 
the Prospectus, or any amendment or supplement thereto.

2.   AGREEMENTS TO SELL AND PURCHASE.  On the basis of the representations 
and warranties contained in this Agreement, and subject to its terms and 
conditions, the Company hereby agrees to sell to the several Underwriters, 
and each Underwriter agrees, severally and not jointly, to purchase from the 
Company the respective numbers of Firm Shares set forth in Schedule I hereto 
opposite its name at $24.345 a share (the "Purchase Price").

On the basis of the representations and warranties contained in this 
Agreement, and subject to its terms and conditions, the Company agrees to 
sell to the Underwriters the Additional Shares, and the Underwriters shall 
have a one-time right to purchase, severally and not jointly, up to 210,000  
Additional Shares at the Purchase Price.  If you, on behalf of the 
Underwriters, elect to exercise such option, you shall so notify the Company 
in writing not later than 30 days after the date of this Agreement, which 
notice shall specify the number of Additional Shares to be purchased by the 
Underwriters and the date on which such shares are to be purchased.  Such 
date may be the same as the Closing Date (as defined below) but not earlier 
than the Closing Date nor later than ten business days after the date of such 
notice.  Additional Shares may be purchased as provided in 

                                     - 2 -
<PAGE>

Section 4 hereof solely for the purpose of covering over-allotments made in 
connection with the offering of the Firm Shares.  If any Additional Shares 
are to be purchased, each Underwriter agrees, severally and not jointly, to 
purchase the number of Additional Shares (subject to such adjustments to 
eliminate fractional shares as you may determine) that bears the same 
proportion to the total number of Additional Shares to be purchased as the 
number of Firm Shares set forth in Schedule I hereto opposite the name of 
such Underwriter bears to the total number of Firm Shares.

The Company hereby agrees that, without the prior written consent of Morgan 
Stanley & Co. Incorporated on behalf of the Underwriters, it will not, during 
the period ending 30 days after the date of the Prospectus, (i) offer, 
pledge, sell, contract to sell, sell any option or contract to purchase, 
purchase any option or contract to sell, grant any option, right or warrant 
to purchase, lend, or otherwise transfer or dispose of, directly or 
indirectly, any shares of Common Stock or any securities convertible into or 
exercisable or exchangeable for Common Stock unless such securities are not 
convertible into or exercisable or exchangeable for Common Stock within such 
30-day period or (ii) enter into any swap or other arrangement that transfers 
to another, in whole or in part, any of the economic consequences of 
ownership of the Common Stock, whether any such transaction described in 
clause (i) or (ii) above is to be settled by delivery of Common Stock or such 
other securities, in cash or otherwise.  The foregoing sentence shall not 
apply to (A) the Shares to be sold hereunder, (B) the issuance by the Company 
of shares of Common Stock upon the exercise of an option or warrant or the 
conversion or redemption of a security outstanding on the date hereof of 
which exercise, conversion or redemption the Underwriters have been advised 
in writing, (C) the offering or issuance of Common Stock or the granting of 
options to purchase shares of Common Stock pursuant to the Company's employee 
and director benefit plans or (D) the issuance of additional partnership 
units of the The Macerich Partnership, L.P. in connection with acquisitions 
of properties provided that such units are not convertible into Common Stock 
during such 30-day period.

3.   TERMS OF PUBLIC OFFERING.  The Company is advised by you that the 
Underwriters propose to make a public offering of their respective portions 
of the Shares as soon as, in your judgment, it is advisable.  The Company is 
further advised by you that the Shares are to be offered to the public 
initially at $25.625 a share (the "Public Offering Price").

4.   PAYMENT AND DELIVERY.  Payment for the Firm Shares shall be made to the 
Company in Federal or other funds immediately available in New York City 
against delivery of such Firm Shares for the respective accounts of the 
several Underwriters at 10:00 a.m., New York City time, on December 14, 1998, 
or at such other time on the same or such other date, not later than December 
21, 1998, as shall be designated in writing by you.  The time and date of 
such payment are hereinafter referred to as the "Closing Date".

Payment for any Additional Shares shall be made to the Company in Federal or 
other funds immediately available in New York City against delivery of such 
Additional Shares for the respective accounts of the several Underwriters at 
10:00 a.m., New York City time, on the date specified in the notice described 
in Section 2 or at such other time on the same or on such other date, 

                                     - 3 -
<PAGE>

in any event not later than January 18, 1999, as shall be designated in 
writing by you.  The time and date of such payment are hereinafter referred 
to as the "Option Closing Date".

The parties acknowledge and agree that the Shares shall be maintained in book
entry only form.  The Shares to be purchased hereunder shall be registered in
such names and in such denominations as you shall request prior to 1:00 p.m.,
New York City time, on the business day prior to the Closing Date or the Option
Closing Date, as the case may be.  The Firm Shares and Additional Shares shall
be delivered to you on the Closing Date or the Option Closing Date, as the case
may be, for the respective accounts of the several Underwriters, with any
transfer taxes payable in connection with the transfer of the Shares to the
Underwriters duly paid, against payment of the Purchase Price therefor.

5.   AGREEMENTS OF THE COMPANY.  The Company agrees with the Underwriters as
follows:

(a)  The Company will (i) prepare a Prospectus Supplement setting forth the
number of Shares covered thereby and their terms not otherwise specified in the
Prospectus pursuant to which the Shares are being issued, the names of the
Underwriters and the number of Shares which each  Underwriter has agreed to
purchase, the price at which the Shares are to be purchased by the Underwriters
from the Company and such other information as the Underwriters and the Company
deem appropriate in connection with the offering of the Shares and file the
Prospectus in a form approved by you pursuant to Rule 424(b) under the Act no
later than the Commission's close of business on the second business day
following the date of the determination of the offering price of the Shares;
(ii) during such period after the first date of the public offering of the
Shares as in the opinion of counsel for the Underwriters the Prospectus is
required by law to be delivered in connection with sales by an Underwriter or
dealer, not file any amendment to the Registration Statement or supplement to
the Prospectus of which you shall not have been previously advised and furnished
with a copy or to which you shall have reasonably objected in writing or which
is not in compliance with the Rules and Regulations; and (iii) during such
period after the first date of the public offering of the Shares as in the
opinion of counsel for the Underwriters the Prospectus is required by law to be
delivered in connection with sales by an Underwriter or dealer, promptly notify
you after it shall have received notice thereof of the time when any amendment
to the Registration Statement becomes effective or when any supplement to
Prospectus has been filed.

(b)  The Company will advise you promptly and, if requested by you, will confirm
such advice in writing: (i) of any request by the Commission for amendment of or
a supplement to the Registration Statement, any Prepricing Prospectus Supplement
or the Prospectus or for additional information; (ii) of the issuance by the
Commission of any stop order suspending the effectiveness of the Registration
Statement or of the suspension of qualification of the Shares for offering or
sale in any jurisdiction or the initiation of any proceeding for such purpose;
and (iii) within the period of time referred to in the first sentence of
paragraph (f) below, of any change in the Company's condition (financial or
other), business, prospects, properties, net worth or results of operations, or
of the happening of any event, which makes any statement of a material fact made
in the Registration Statement or the Prospectus (as then amended or
supplemented) untrue or which 

                                     - 4 -
<PAGE>

requires the making of any additions to or changes in the Registration 
Statement or the Prospectus (as then amended or supplemented) in order to 
state a material fact required by the Act to be stated therein or necessary 
in order to make the statements therein not misleading, or of the necessity 
to amend or supplement the Prospectus (as then amended or supplemented) to 
comply with the Act or any other law.  If at any time the Commission shall 
issue any stop order suspending the effectiveness of the Registration 
Statement, the Company will make every reasonable effort to obtain the 
withdrawal of such order at the earliest possible time.

(c)  [Intentionally Deleted]

(d)  Prior to the Closing Date, the Company will not file any amendment to 
the Registration Statement or make any amendment or supplement to the 
Prospectus of which you shall not previously have been advised or to which, 
after you shall have received a copy of the document proposed to be filed, 
you shall reasonably object.

(e)  The Company will use its best efforts to meet the requirements to 
qualify as a real estate investment trust (a "REIT") under the Internal 
Revenue Code of 1986, as amended (the "Code") unless the Company's Board of 
Directors determines by resolution that it is in the best interests of the 
Company's stockholders not to so qualify.

(f)  As soon after the execution and delivery of this Agreement as possible 
and thereafter from time to time for such period as in the opinion of counsel 
for the Underwriters a prospectus is required by the Act to be delivered in 
connection with sales by the Underwriters or any dealer, the Company will 
expeditiously deliver to the Underwriters and each dealer, without charge, as 
many copies of the Prospectus (and of any amendment or supplement thereto) as 
you may reasonably request.  The Company consents to the use of the 
Prospectus (and of any amendment or supplement thereto) in accordance with 
the provisions of the Act and with the securities or Blue Sky laws of the 
jurisdictions in the United States in which the Shares are offered by the 
Underwriters and by all dealers to whom Shares may be sold, both in 
connection with the offering and sale of the Shares and for such period of 
time thereafter as the Prospectus is required by the Act to be delivered in 
connection with sales by any Underwriter or dealer.  If during such period of 
time any event shall occur that in the judgment of the Company or in the 
reasonable opinion of counsel for the Underwriters is required to be set 
forth in the Prospectus (as then amended or supplemented) or should be set 
forth therein in order to make the statements therein, in the light of the 
circumstances under which they were made, not misleading, or if it is 
necessary to supplement or amend the Prospectus (or to file under the 
Exchange Act any document which, upon filing, becomes an Incorporated 
Document) in order to comply with the Act or any other law, the Company will 
forthwith prepare and, subject to the provisions of paragraph (d) above, file 
with the Commission an appropriate supplement or amendment thereto (or to 
such document), and will expeditiously furnish to the Underwriters and any 
dealers a reasonable number of copies thereof.  In the event that the Company 
and you agree that the Prospectus should be amended or supplemented, the 
Company, if requested by you, will promptly issue a press release announcing 
or disclosing the matters to be covered by the proposed amendment or 
supplement.

                                     - 5 -
<PAGE>

(g)  The Company will cooperate with you and your counsel in connection with 
the registration or qualification of the Shares for offering and sale by the 
Underwriters and by any dealers under the securities or Blue Sky laws of such 
jurisdictions in the United States as you may designate and will file such 
consents to service of process or other documents necessary or appropriate in 
order to effect such registration or qualification; provided that in no event 
shall the Company be obligated to qualify to do business in any jurisdiction 
where it is not now so qualified or to take any action which would subject it 
to service of process in suits, other than those arising out of the offering 
or sale of the Shares, in any jurisdiction where it is not now so subject.

(h)  The Company will make generally available to its security holders a 
consolidated earnings statement, which need not be audited, covering a twelve 
month period commencing after the effective date of the Registration 
Statement and ending not later than 15 months thereafter, as soon as 
practicable after the end of such period, which consolidated earnings 
statement shall satisfy the provisions of Section 11(a) of the Act.

(i)  During the period of three years hereafter, the Company will furnish to 
you a copy of each report of the Company mailed to stockholders that is not 
available via the EDGAR System.

(j)  If this Agreement shall terminate or shall be terminated after execution 
pursuant to any provisions hereof (otherwise than by notice given by you 
terminating this Agreement pursuant to Section 10 or Section 12 hereof, or by 
reason of your default) or if this Agreement shall be terminated by the 
Underwriters because of any failure or refusal on the part of the Company to 
comply with the terms or fulfill any of the conditions of this Agreement, the 
Company agrees to reimburse you for all out-of-pocket expenses (including 
fees and expenses of your counsel) incurred by you in connection herewith, 
but the Company shall not in any event be liable to the Underwriters for 
damages on account of loss of anticipated profits from the sale by it of the 
Shares.

(k)  The Company will apply the net proceeds from the sale of the Shares 
substantially in accordance with the description set forth in the Prospectus 
Supplement.

(l)  Except as stated in this Agreement and in the Prospectus, the Company 
has not taken, nor will it take, directly or indirectly, any action designed 
to or that might reasonably be expected to cause or result in stabilization 
or manipulation of the price of the Common Stock to facilitate the sale or 
resale of the Shares.

(m)  The Company will use its best efforts to have the shares of Common Stock 
which it agrees to sell under this Agreement listed, subject to notice of 
issuance, on the New York Stock Exchange on or before the Closing Date.

6.   REPRESENTATIONS AND WARRANTIES OF THE COMPANY.  The Company represents 
and warrants to the Underwriters that:

(a)  The Company and the transactions contemplated by this Agreement meet the 
requirements for using Form S-3 under the Act.  The registration statement in 
the form in which it became or 

                                     - 6 -
<PAGE>

becomes effective and also in such form as it may be when any posteffective 
amendment thereto shall become effective and the Prospectus and any 
supplement or amendment thereto when filed with the Commission under Rule 
424(b) under the Act, complied or will comply in all material respects with 
the provisions of the Act and will not at any such times contain an untrue 
statement of a material fact or omit to state a material fact required to be 
stated therein or necessary to make the statements therein not misleading, 
except that this representation and warranty does not apply to statements in 
or omissions from the registration statement or the prospectus made in 
reliance upon and in conformity with information relating to the Underwriters 
furnished to the Company in writing by or on behalf of the Underwriters 
through you expressly for use therein.

(b)  The Incorporated Documents heretofore filed, when they were filed (or, 
if any amendment with respect to any such document was filed, when such 
amendment was filed), conformed in all material respects with the 
requirements of the Exchange Act and the rules and regulations thereunder, 
any further Incorporated Documents so filed will, when they are filed, 
conform in all material respects with the requirements of the Exchange Act 
and the rules and regulations thereunder; no such document when it was filed 
(or, if an amendment with respect to any such document was filed, when such 
amendment was filed), contained an untrue statement of a material fact or 
omitted to state a material fact required to be stated therein or necessary 
in order to make the statements therein, in light of the circumstances under 
which they were made, not misleading; and no such further document, when it 
is filed, will contain an untrue statement of a material fact or will omit to 
state a material fact required to be stated therein or necessary in order to 
make the statements therein, in light of the circumstances under which they 
were made, not misleading.

(c)  All the outstanding shares of Common Stock of the Company have been duly 
authorized and validly issued, are fully paid and nonassessable and are free 
of any preemptive or similar rights; the Shares have been duly authorized 
and, when issued and delivered to the Underwriters against payment therefor 
in accordance with the terms hereof, will be validly issued, fully paid and 
nonassessable and free of any preemptive or similar rights.  The Common 
Stock, the Series A Cumulative Convertible Redeemable Preferred Stock and the 
Series B Cumulative Convertible Redeemable Preferred Stock of the Company 
each conforms to the description thereof in the Registration Statement and 
the Prospectus.

(d)  The Company is a corporation duly organized and validly existing in good 
standing under the laws of the State of Maryland with corporate power and 
authority to own, lease and operate its properties and to conduct its 
business as described in the Registration Statement and the Prospectus, and 
is duly registered and qualified to conduct its business and is in good 
standing in each jurisdiction or place where the nature of its properties or 
the conduct of its business requires such registration or qualification, 
except where the failure so to register or qualify does not have a material 
adverse effect on the condition (financial or other), business, properties, 
net worth or results of operations of the Company and the Subsidiaries (as 
hereinafter defined) taken as a whole.

(e)  All the Company's subsidiaries (collectively, the "Subsidiaries") are 
listed on Schedule III hereto.  Each Subsidiary is a corporation, general 
partnership, limited partnership, or limited liability company, as the case 
may be, duly organized, validly existing and in good standing in the 

                                     - 7 -
<PAGE>

jurisdiction of its incorporation or organization, with full corporate, 
partnership or limited liability company power and authority to own, lease 
and operate its properties and to conduct its business as described in the 
Registration Statement and the Prospectus, and is duly registered and 
qualified to conduct its business and is in good standing in each 
jurisdiction or place where the nature of its properties or the conduct of 
its business requires such registration or qualification, except where the 
failure so to register or qualify does not, in the aggregate, have a material 
adverse effect on the condition (financial or other), business, properties, 
net worth or results of operations of the Company and the Subsidiaries, taken 
as a whole; except as set forth on Schedule III, all the outstanding shares 
of capital stock of each of the Subsidiaries have been duly authorized and 
validly issued, are fully paid and nonassessable.  All of the interests owned 
or held by the Company, directly or indirectly, in each of the Subsidiaries 
are free and clear of any lien, adverse claim, security interest, equity or 
other encumbrance, except for such as would not have a material adverse 
effect on the condition (financial or other), business, properties, net worth 
or results of operations of the Company and the Subsidiaries, taken as a 
whole.

(f)  All of the joint ventures in which the Company or any Subsidiary owns 
any interest (the "Joint Ventures") are listed on Schedule III hereto.  The 
Company's (or Subsidiary's, as the case may be) ownership interest in such 
Joint Venture is as set forth on Schedule III.  To the knowledge of the 
Company, each of the Joint Ventures possesses such certificates, 
authorizations or permits issued by the appropriate state, federal or foreign 
regulatory agencies or bodies necessary to conduct the business now being 
conducted by it, as described or incorporated by reference in the Prospectus, 
and none of the Joint Ventures has received notice of any proceedings 
relating to the revocation or modification of any such certificate, authority 
or permit which singly or in the aggregate, if the subject of unfavorable 
ruling or decision, would have a material adverse effect on the condition 
(financial or other), business, properties, net worth or results of 
operations of the Company and the Subsidiaries, taken as a whole; and, to the 
knowledge of the Company, each of the Joint Ventures has good and marketable 
fee simple title to all of its real property and marketable title to any 
improvements thereon and all other assets that are used in the operation of 
the Joint Venture's business, except where the failure to have such title 
would not have a material adverse effect on the condition (financial or 
other), business, properties, net worth or results of operations of the 
Company and the Subsidiaries, taken as a whole.

(g)  There are no legal or governmental proceedings pending or, to the 
knowledge of the Company, threatened, against the Company or any of the 
Subsidiaries, or to which the Company or any of the Subsidiaries, or to which 
any of their respective properties is subject, that are required to be 
described in the Registration Statement or the Prospectus but are not 
described as required, and there are no agreements, contracts, indentures, 
leases or other instruments that are required to be described in the 
Registration Statement or the Prospectus or to be filed as an exhibit to the 
Registration Statement or any Incorporated Document that are not described or 
filed as required by the Act or the Exchange Act.

(h)  Neither the Company nor any of the Subsidiaries is in violation of its 
certificate or articles of incorporation or bylaws, or other organizational 
documents, or, of any law, ordinance, administrative or governmental rule or 
regulation applicable to the Company or any of the 

                                     - 8 -
<PAGE>

Subsidiaries or of any decree of any court or governmental agency or body 
having jurisdiction over the Company or any of the Subsidiaries, or in 
default in the performance of any obligation, agreement or condition 
contained in any bond, debenture, note or any other evidence of indebtedness 
or in any material agreement, indenture, lease or other instrument to which 
the Company or any of the Subsidiaries is a party or by which any of them or 
any of their respective properties may be bound, except where such violation 
or default does not have a material adverse effect on the condition 
(financial or other), business, properties, net worth or results of 
operations of the Company and the Subsidiaries, taken as a whole.

(i)  Neither the issuance and sale of the Shares, the execution, delivery or 
performance of this Agreement by the Company nor the consummation by the 
Company of the transactions contemplated hereby (i) requires any consent, 
approval, authorization or other order of or registration or filing with, any 
court, regulatory body, administrative agency or other governmental body, 
agency or official (except such as may be required for the registration of 
the Shares under the Act and the Exchange Act and compliance with the 
securities or Blue Sky laws of various jurisdictions, all of which have been 
or will be effected in accordance with this Agreement) or conflicts or will 
conflict with or constitutes or will constitute a breach of, or a default 
under, the certificate or articles of incorporation or bylaws, or other 
organizational documents, of the Company or any of the Subsidiaries or (ii) 
conflicts or will conflict with or constitutes or will constitute a breach 
of, or a default under, any agreement, indenture, lease or other instrument 
to which the Company or any of the Subsidiaries is a party or by which any of 
them or any of their respective properties may be bound, or violates or will 
violate any statute, law, regulation or filing or judgment, injunction, order 
or decree applicable to the Company or any of the Subsidiaries or any of 
their respective properties, or will result in the creation or imposition of 
any lien, charge or encumbrance upon any property or assets of the Company or 
any of the Subsidiaries pursuant to the terms of any agreement or instrument 
to which any of them is a party or by which any of them may be bound or to 
which any of the property or assets of any of them is subject except for such 
breaches or defaults under any agreement, indenture, lease or other 
instrument which would not have a material adverse effect on the condition 
(financial or other), business, properties, net worth or results of 
operations of the Company and the Subsidiaries, taken as a whole.

(j)  PricewaterhouseCoopers LLP, KPMG Marwick LLP and Deloitte & Touche LLP, 
the accounting firms which have certified or shall certify the financial 
statements included or incorporated by reference in the Registration 
Statement and the Prospectus (or any amendment or supplement thereto), are 
independent public accounting firms within the meaning of the Act and the 
Rules and Regulations.

(k)  The financial statements, together with related schedules and notes, 
included or incorporated by reference in the Registration Statement and the 
Prospectus (and any amendment or supplement thereto), present fairly the 
consolidated financial position, results of operations and changes in 
financial position of the Company and the Subsidiaries on the basis stated in 
the Registration Statement at the respective dates or for the respective 
periods to which they apply; such statements and related schedules and notes 
have been prepared in accordance with generally accepted accounting 
principles consistently applied throughout the periods involved, except as 
disclosed 

                                     - 9 -
<PAGE>

therein; and the other financial and statistical information and data 
included or incorporated by reference in the Registration Statement and the 
Prospectus (and any amendment or supplement thereto) are fairly presented and 
prepared on a basis consistent with such financial statements and the books 
and records of the Company and the Subsidiaries.

(l)  The execution and delivery of, and the performance by the Company of its 
obligations under, this Agreement have been duly and validly authorized by 
the Company, and this Agreement has been duly executed and delivered by the 
Company and constitutes the valid and legally binding agreement of the 
Company, enforceable against the Company in accordance with its terms, except 
as rights to indemnity and contribution hereunder may be limited by federal 
or state securities laws.

(m)  Except as disclosed in the Registration Statement and the Prospectus (or 
any amendment or supplement thereto), subsequent to the respective dates as 
of which such information is given in the Registration Statement and the 
Prospectus (or any amendment or supplement thereto), neither the Company nor 
any of the Subsidiaries has incurred any liability or obligation, direct or 
contingent, or entered into any transaction, not in the ordinary course of 
business, that is material to the Company and the Subsidiaries taken as a 
whole, and there has not been any change in the capital stock, or material 
increase in the short-term debt or long-term debt, of the Company or any of 
the Subsidiaries other than as a result of borrowings made by the Company 
under its credit facility in the ordinary course of business, or any material 
adverse change, or any development involving or which may reasonably be 
expected to involve, a prospective material adverse change, in the condition 
(financial or other), business, net worth or results of operations of the 
Company and the Subsidiaries taken as a whole.

(n)  (i)  The Company has good and marketable title to all of the properties 
(including the Properties listed as wholly owned by the Company or its 
affiliates on Schedule II hereto) and assets reflected in the financial 
statements (or as described in or incorporated by reference into the 
Registration Statement or Prospectus) hereinabove described, subject to no 
lien, mortgage, pledge, charge or encumbrance of any kind except those 
reflected in such financial statements (or as described in or incorporated by 
reference into the Registration Statement or Prospectus) or which are not 
material in amount; (ii) the Company occupies its leased properties under 
valid and binding leases conforming, to the extent such leases are described 
therein, to the description thereof set forth in or incorporated by reference 
into the Registration Statement or Prospectus; (iii) no tenant of any of the 
Properties is in default under any of the leases pursuant to which any 
property is leased (and the Company does not know of any event which, but for 
the passage of time or the giving of notice, or both, would constitute a 
default under any of such leases) other than such defaults that would not 
have a material adverse effect on the condition (financial or other), 
business, properties, net worth or results of operations of the Company and 
the Subsidiaries taken as a whole; (iv) no person has an option to purchase 
all or part of any Property or any interest therein other than (x) rights 
with respect to certain Properties owned by the Joint Ventures in favor of 
the partners to such Joint Ventures pursuant to the agreements governing the 
Joint Ventures or (y) options which, if exercised, would not have a material 
adverse effect on the Company and the Subsidiaries, taken as a whole; (v) 
each of the Properties complies with all applicable codes, laws and 
regulations (including, without limitation, building and zoning codes, laws 
and regulations and laws relating to access to 

                                     - 10 -
<PAGE>

the properties) and with all agreements between the Company and third parties 
relating to the ownership or use of any Property by the Company, except if 
and to the extent disclosed in the Registration Statement or the Prospectus 
and except for such failures to comply that would not have a material adverse 
effect on the condition, financial or otherwise, or on the earnings, assets, 
business affairs or business prospects of the Company and the Subsidiaries 
taken as a whole; (vi) there is in effect for the assets of the Company and 
the Properties insurance coverages that are commercially reasonable and that 
are consistent with the types and amounts of insurance typically maintained 
by prudent owners of similar assets, and the Company has not received from 
any insurance company notice of any material defects or deficiencies 
affecting the insurability of any such assets; and (vii) the Company does not 
have any knowledge of any pending or threatened condemnation proceedings, 
zoning change, or other similar proceeding or action that will in any 
material respect affect the size of, use of, improvements on, construction on 
or access to the Properties, except for such proceedings or actions that 
would not have a material adverse effect on the condition (financial or 
other), business, properties, net worth or results of operations of the 
Company and the Subsidiaries, taken as a whole.

(o)  The Company has title policies in effect or binding commitments from 
title insurance companies for the issuance of title insurance on each of the 
Properties, except where the failure to have such title insurance would not 
have a material adverse effect on the condition (financial or other), 
business, properties, net worth or results of operations of the Company and 
the Subsidiaries, as a whole.

(p)  The Company has not distributed and, prior to the later to occur of (i) 
the Closing Date and (ii) completion of the distribution of the Shares, will 
not distribute any offering material in connection with the offering and sale 
of the Shares other than the Registration Statement, the Prepricing 
Prospectus, the Prospectus or other materials, if any, permitted by the Act.

(q)  The Company and each of the Subsidiaries has such permits, licenses, 
franchises and authorizations of governmental or regulatory authorities 
("permits") and agreements with third parties relating to ownership or use of 
any Property by the Company as are necessary to own its respective properties 
and to conduct its business in the manner described in the Prospectus, 
subject to such qualifications as may be set forth in the Prospectus and 
except where the omission to have such permits and agreements would not have 
a material adverse effect on the condition (financial or other), business, 
properties, net worth or results of operations of the Company and the 
Subsidiaries, taken as a whole; the Company and each of the Subsidiaries has 
fulfilled and performed all its material obligations with respect to such 
permits and agreements and no event has occurred which allows, or after 
notice or lapse of time would allow, revocation or termination thereof or 
results in any other material impairment of the rights of the holder of any 
such permit or agreement, subject in each case to such qualification as may 
be set forth in the Prospectus; and, except as described in the Prospectus, 
none of such permits or agreements contains any restriction that would have a 
material adverse effect on the condition (financial or other), business, 
properties, net worth or results of operations of the Company and the 
Subsidiaries, taken as a whole.

                                     - 11 -
<PAGE>

(r)  The Company maintains a system of internal accounting controls 
sufficient to provide reasonable assurances that (i) transactions are 
executed in accordance with management's general or specific authorization; 
(ii) transactions are recorded as necessary to permit preparation of 
financial statements in conformity with generally accepted accounting 
principles and to maintain accountability for assets; (iii) access to assets 
is permitted only in accordance with management's general or specific 
authorization; and (iv) the recorded accountability for assets is compared 
with existing assets at reasonable intervals and appropriate action is taken 
with respect to any differences.

(s)  To the Company's knowledge, neither the Company nor any of its 
Subsidiaries nor any employee or agent of the Company or any Subsidiary has 
made any payment of funds of the Company or any Subsidiary or received or 
retained any funds in violation of any law, rule or regulation, which 
payment, receipt or retention of funds is of a character required to be 
disclosed in the Prospectus.

(t)  The Company and each of the Subsidiaries have filed all federal, state 
and foreign tax returns required to be filed, which returns are complete and 
correct, and neither the Company nor any Subsidiary is in default in the 
payment of any taxes which were payable pursuant to said returns or any 
assessments with respect thereto, except where such failure to file or 
default in payment would not have a material adverse effect on the condition 
(financial or other), business, properties, net worth or results of 
operations of the Company and the Subsidiaries, taken as a whole.

(u)  No holder of any security of the Company currently has any right to 
require registration of shares of Common Stock or any other security of the 
Company because of the filing of the registration statement or consummation 
of the transactions contemplated by this Agreement.

(v)  The Company and the Subsidiaries own or possess in the United States all 
patents, trademarks, trademark registrations, service marks, service mark 
registrations, trade names, copyrights, licenses, inventions, trade secrets 
and rights described in the Prospectus as being owned by them or any of them 
or necessary for the conduct of their respective businesses and the Company 
is not aware of any claim to the contrary or any challenge by any other 
person in the United States or in any foreign jurisdiction to the rights of 
the Company and the Subsidiaries with respect to the foregoing which claim or 
challenge, if determined adversely to the Company, would have a material 
adverse effect on the condition (financial or otherwise), business, 
properties, net worth or results of operations of the Company and the 
Subsidiaries, taken as a whole.

(w)  Except as otherwise disclosed in the Prospectus, the Company has not 
authorized or conducted and does not have knowledge of the generation, 
transportation, storage, presence, use, treatment, disposal, release, or 
other handling of any hazardous substance, hazardous waste, hazardous 
material, hazardous constituent, toxic substance, pollutant, contaminant, 
asbestos, radon, polychlorinated biphenyls ("PCBs"), petroleum product or 
waste (including crude oil or any fraction thereof), natural gas, liquefied 
gas, synthetic gas or other material defined, regulated, controlled or 
potentially subject to any remediation requirement under any environmental 
law (collectively, "Hazardous Materials"), on, in, under or affecting any 
real property currently leased or owned or by any means controlled by the 
Company, including the Properties (the "Real Property"), except 

                                     - 12 -
<PAGE>

where such non-compliance would not have a material adverse effect on the 
condition (financial or other), business, properties, net worth or results of 
operations of the Company and the Subsidiaries, taken as a whole; to the 
knowledge of the Company, the Real Property and the Company's operations with 
respect to the Real Property are in compliance with all federal, state and 
local laws, ordinances, rules, regulations and other governmental 
requirements relating to pollution, control of chemicals, management of 
waste, discharges of materials into the environment, health, safety, natural 
resources, and the environment (collectively, "Environmental Laws"), except 
where such non-compliance would not have a material adverse effect on the 
condition (financial or other), business, properties, net worth or results of 
operations of the Company and the Subsidiaries, taken as a whole, and the 
Company has, and is in compliance with, all licenses, permits, registrations 
and government authorizations necessary to operate under all applicable 
Environmental Laws, except where the failure to have or comply with such 
license, permit, registration or authorization would not have a material 
adverse effect on the condition (financial or other), business, properties, 
net worth or results of operations of the Company and the Subsidiaries, taken 
as a whole.  Except as otherwise disclosed in the Prospectus, the Company has 
not received any written notice from any governmental entity and to the 
knowledge of the Company there is no pending or threatened claim, litigation 
or any administrative agency proceeding that: alleges a violation of any 
Environmental Laws by the Company; alleges that the Company is a liable party 
or a potentially responsible party under the Comprehensive Environmental 
Response, Compensation and Liability Act, 42 U.S.C. Section  9601, ET SEQ., 
or any state superfund law; has resulted in or could result in the attachment 
of an environmental lien on any of the Real Property; or alleges that the 
Company is liable for any contamination of the environment, contamination of 
the Real Property, damage to natural resources, property damage, or personal 
injury based on their activities or the activities of their predecessors or 
third parties (whether at the Real Property or elsewhere) involving Hazardous 
Materials, and arising under the Environmental Laws or common law principles, 
except for such claims, litigation or proceedings as would not be expected to 
have a material adverse effect on the condition (financial or other), 
business, properties net worth or results of the Company and the 
Subsidiaries, taken as a whole.

(x)  The Company is organized in conformity with the requirements for 
qualification as a real estate investment trust under the Code, and the 
Company's method of operation enables it to meet the requirements for 
taxation as a real estate investment trust under the Code.

(y)  None of the Company nor any Subsidiary is or will become as a result of 
the transactions contemplated hereby, "an investment company," or a company 
"controlled" by an "investment company," within the meaning of the Investment 
Company Act of 1940, as amended.

(z)  The statements set forth in the Prospectus under the caption "Certain 
Federal Income Tax Considerations" and "Certain Federal Income Tax 
Considerations to Holders of Common Stock", insofar as they purport to 
describe the provisions of the laws and documents referred to therein, are 
accurate and complete.

                                     - 13 -
<PAGE>

7.   INDEMNIFICATION AND CONTRIBUTION.

(a)  The Company agrees to indemnify and hold harmless each Underwriter and 
each person, if any, who controls any Underwriter within the meaning of 
either Section 15 of the Act or Section 20 of the Exchange Act from and 
against any and all losses, claims, damages and liabilities (including, 
without limitation, any legal or other expenses reasonably incurred in 
connection with defending or investigating any such action or claim) caused 
by any untrue statement or alleged untrue statement of a material fact 
contained in the Registration Statement or any amendment thereof, any 
preliminary prospectus or the Prospectus (as amended or supplemented if the 
Company shall have furnished any amendments or supplements thereto), or 
caused by any omission or alleged omission to state therein a material fact 
required to be stated therein or necessary to make the statements therein not 
misleading, except insofar as such losses, claims, damages or liabilities are 
caused by any such untrue statement or omission or alleged untrue statement 
or omission based upon information relating to any Underwriter furnished to 
the Company in writing by such Underwriter through you expressly for use 
therein; PROVIDED, HOWEVER, that the foregoing indemnity agreement with 
respect to any preliminary prospectus shall not inure to the benefit of any 
Underwriter from whom the person asserting any such losses, claims, damages 
or liabilities purchased Shares, or any person controlling such Underwriter, 
if a copy of the Prospectus (as then amended or supplemented if the Company 
shall have furnished any amendments or supplements thereto) was not sent or 
given by or on behalf of such Underwriter to such person, if required by law 
so to have been delivered, at or prior to the written confirmation of the 
sale of the Shares to such person, and if the Prospectus (as so amended or 
supplemented) would have cured the defect giving rise to such losses, claims, 
damages or liabilities, unless such failure is the result of noncompliance by 
the Company with Section 7(a) hereof.

(b)  Each Underwriter agrees, severally and not jointly, to indemnify and 
hold harmless the Company, its directors, its officers who sign the 
Registration Statement and each person, if any, who controls the Company 
within the meaning of either Section 15 of the Act or Section 20 of the 
Exchange Act to the same extent as the foregoing indemnity from the Company 
to such Underwriter, but only with reference to information relating to such 
Underwriter furnished to the Company in writing by such Underwriter through 
you expressly for use in the Registration Statement, any preliminary 
prospectus, the Prospectus or any amendments or supplements thereto.

(c)  In case any proceeding (including any governmental investigation) shall 
be instituted involving any person in respect of which indemnity may be 
sought pursuant to Section 7(a) or 7(b), such person (the "indemnified 
party") shall promptly notify the person against whom such indemnity may be 
sought (the "indemnifying party") in writing and the indemnifying party, upon 
request of the indemnified party, shall retain counsel reasonably 
satisfactory to the indemnified party to represent the indemnified party and 
any others the indemnifying party may designate in such proceeding and shall 
pay the fees and disbursements of such counsel related to such proceeding.  
In any such proceeding, any indemnified party shall have the right to retain 
its own counsel, but the fees and expenses of such counsel shall be at the 
expense of such indemnified party unless (i) the indemnifying party and the 
indemnified party shall have mutually agreed to the retention of such 

                                     - 14 -
<PAGE>

counsel or (ii) the named parties to any such proceeding (including any 
impleaded parties) include both the indemnifying party and the indemnified 
party and representation of both parties by the same counsel would be 
inappropriate due to actual or potential differing interests between them.  
It is understood that the indemnifying party shall not, in respect of the 
legal expenses of any indemnified party in connection with any proceeding or 
related proceedings in the same jurisdiction, be liable for the fees and 
expenses of more than one separate firm (in addition to any local counsel) 
for all such indemnified parties and that all such fees and expenses shall be 
reimbursed as they are incurred.  Such firm shall be designated in writing by 
Morgan Stanley & Co. Incorporated, in the case of parties indemnified 
pursuant to Section 7(a), and by the Company, in the case of parties 
indemnified pursuant to Section 7(b).  The indemnifying party shall not be 
liable for any settlement of any proceeding effected without its written 
consent, but if settled with such consent or if there be a final judgment for 
the plaintiff, the indemnifying party agrees to indemnify the indemnified 
party from and against any loss or liability by reason of such settlement or 
judgment. No indemnifying party shall, without the prior written consent of 
the indemnified party, effect any settlement of any pending or threatened 
proceeding in respect of which any indemnified party is or could have been a 
party and indemnity could have been sought hereunder by such indemnified 
party, unless such settlement includes an unconditional release of such 
indemnified party from all liability on claims that are the subject matter of 
such proceeding.

(d)  To the extent the indemnification provided for in Section 7(a) or 7(b) 
is unavailable to an indemnified party or insufficient in respect of any 
losses, claims, damages or liabilities referred to therein, then each 
indemnifying party under such paragraph, in lieu of indemnifying such 
indemnified party thereunder, shall contribute to the amount paid or payable 
by such indemnified party as a result of such losses, claims, damages or 
liabilities (i) in such proportion as is appropriate to reflect the relative 
benefits received by the Company on the one hand and the Underwriters on the 
other hand from the offering of the Shares or (ii) if the allocation provided 
by clause 7(d)(i) above is not permitted by applicable law, in such 
proportion as is appropriate to reflect not only the relative benefits 
referred to in clause 7(d)(i) above but also the relative fault of the 
Company on the one hand and of the Underwriters on the other hand in 
connection with the statements or omissions that resulted in such losses, 
claims, damages or liabilities, as well as any other relevant equitable 
considerations.  The relative benefits received by the Company on the one 
hand and the Underwriters on the other hand in connection with the offering 
of the Shares shall be deemed to be in the same respective proportions as the 
net proceeds from the offering of the Shares (before deducting expenses) 
received by the Company and the total underwriting discounts and commissions 
received by the Underwriters, in each case as set forth in the table on the 
cover of the Prospectus, bear to the aggregate Public Offering Price of the 
Shares.  The relative fault of the Company on the one hand and the 
Underwriters on the other hand shall be determined by reference to, among 
other things, whether the untrue or alleged untrue statement of a material 
fact or the omission or alleged omission to state a material fact relates to 
information supplied by the Company or by the Underwriters and the parties' 
relative intent, knowledge, access to information and opportunity to correct 
or prevent such statement or omission. The Underwriters' respective 
obligations to contribute pursuant to this Section 7 are several in 
proportion to the respective number of Shares they have purchased hereunder, 
and not joint.

                                     - 15 -
<PAGE>

(e)  The Company and the Underwriters agree that it would not be just or 
equitable if contribution pursuant to this Section 7 were determined by PRO 
RATA allocation (even if the Underwriters were treated as one entity for such 
purpose) or by any other method of allocation that does not take account of 
the equitable considerations referred to in Section 7(d).  The amount paid or 
payable by an indemnified party as a result of the losses, claims, damages 
and liabilities referred to in the immediately preceding paragraph shall be 
deemed to include, subject to the limitations set forth above, any legal or 
other expenses reasonably incurred by such indemnified party in connection 
with investigating or defending any such action or claim.  Notwithstanding 
the provisions of this Section 7, no Underwriter shall be required to 
contribute any amount in excess of the amount by which the total price at 
which the Shares underwritten by it and distributed to the public were 
offered to the public exceeds the amount of any damages that such Underwriter 
has otherwise been required to pay by reason of such untrue or alleged untrue 
statement or omission or alleged omission.  No person guilty of fraudulent 
misrepresentation (within the meaning of Section 11(f) of the Act) shall be 
entitled to contribution from any person who was not guilty of such 
fraudulent misrepresentation.  The remedies provided for in this Section 7 
are not exclusive and shall not limit any rights or remedies which may 
otherwise be available to any indemnified party at law or in equity.

(f)  The indemnity and contribution provisions contained in this Section 7 
and the representations, warranties and other statements of the Company 
contained in this Agreement shall remain operative and in full force and 
effect regardless of (i) any termination of this Agreement, (ii) any 
investigation made by or on behalf of any Underwriter or any person 
controlling any Underwriter or by or on behalf of the Company, its officers 
or directors or any person controlling the Company and (iii) acceptance of 
and payment for any of the Shares; provided that, if the Underwriters with 
actual knowledge of (x) a default in a specific covenant, agreement or 
obligation to be performed by the Company under this Agreement or under any 
closing document, and/or (y) a breach of any specific representation or 
warranty of the Company made in this Agreement or any closing document, 
nonetheless elects to proceed to closing, then upon the consummation of the 
closing, the Underwriters shall be deemed to have waived such default and 
breach and shall have no claim against the Company with respect thereto, or 
any termination right hereunder; provided further that any such waiver shall 
not be deemed to be a waiver of any other default in any covenant, agreement 
or obligation to be performed by the Company under this Agreement or under 
any closing document of which the Underwriters do not have actual knowledge 
or any other breach of any representation or warranty of the Company made in 
this Agreement or any closing document of which the Underwriters do not have 
actual knowledge.

8.   CONDITIONS OF UNDERWRITERS' OBLIGATIONS.  The obligations of the 
Underwriters to purchase the Shares hereunder are subject to the following 
conditions:

(a)  All filings required by Rules 424 and 430A under the Act shall have been
timely made; no stop order suspending the effectiveness of the registration
statement shall have been issued and no proceeding for that purpose shall have
been instituted or, to the knowledge of the Company or the Underwriters,
threatened by the Commission, and any request of the Commission for additional

                                     - 16 -
<PAGE>

information (to be included in the registration statement or the prospectus or
otherwise) shall have been complied with to your reasonable satisfaction.

(b)    Subsequent to the effective date of this Agreement, there shall not 
have occurred (i) any downgrading, nor shall any notice have been given of 
any intended or potential downgrading or of any review for a possible change 
that does not indicate the direction of the possible change, in the rating 
accorded any of the Company's securities by any "nationally recognized 
statistical rating organization," as such term is defined for purposes of 
Rule 436(g)(2) under the Act; (ii) any change, or any development involving a 
prospective change, in the condition, financial or otherwise, or in the 
earnings, business or operations of the Company and its subsidiaries, taken 
as a whole, from that set forth in the Prospectus (exclusive of any 
amendments or supplements thereto subsequent to the date of this Agreement) 
that, in your judgment, is material and adverse and that makes it, in your 
judgment, impracticable to market the Shares on the terms and in the manner 
contemplated in the Prospectus; or (iii) any event or development relating to 
or involving the Company or any officer or director of the Company which 
makes any statement made in the Prospectus untrue in any material respect or 
which, in the opinion of the Company and its counsel or the Underwriters and 
their counsel, requires the making of any addition to or change in the 
Prospectus in order to state a material fact required by the Act or any other 
law to be stated therein or necessary in order to make the statements therein 
not misleading, if amending or supplementing the Prospectus to reflect such 
event or development would, in your opinion, have a material adverse effect 
on the market for the Shares.

(c)  You shall have received on the Closing Date, an opinion of O'Melveny & 
Myers LLP, special counsel for the Company, dated the Closing Date and 
addressed to you substantially in the form of Annex A hereto.  In rendering 
their opinion as aforesaid, counsel may rely upon an opinion or opinions, 
each dated the Closing Date, of other counsel retained by them or the Company 
as to laws of any jurisdiction, provided that (i) each such local counsel is 
acceptable to you, and (ii) such reliance is expressly authorized by each 
opinion so relied upon and a copy of each such opinion is delivered to you 
and is, in form and substance satisfactory to them and their counsel.

(d)  You shall have received on the Closing Date an opinion of Mayer, Brown & 
Platt, special counsel for the Underwriters, dated the Closing Date and 
addressed to you with respect to the matters referred to in clauses (vi) (as 
to due authorization and valid issuance), (xii), (xv) and the paragraph 
immediately following clause (xix) of Annex A hereto and such other related 
matters as you may request.  In rendering their opinion as aforesaid, counsel 
may rely upon an opinion or opinions, each dated the Closing Date, of other 
counsel retained by them or the Company as to laws of any jurisdiction, 
provided that (1) each such local counsel is acceptable to you, and (2) such 
reliance is expressly authorized by each opinion so relied upon and a copy of 
each such opinion is delivered to you and is, in form and substance 
satisfactory to them and their counsel.

(e)  You shall have received letters addressed to you and dated the date 
hereof and the Closing Date from PricewaterhouseCoopers LLP, independent 
certified public accountants, substantially in the forms heretofore approved 
by you.

                                     - 17 -
<PAGE>

(f)  (i) No stop order suspending the effectiveness of the Registration 
Statement shall have been issued and no proceedings for that purpose shall 
have been taken or, to the knowledge of the Company, shall be contemplated by 
the Commission at or prior to the Closing Date; (ii) there shall not have 
been any change in the capital stock of the Company nor any material increase 
in the short-term or long-term debt of the Company (other than in the 
ordinary course of business) from that set forth or contemplated in the 
Registration Statement or the Prospectus (or any amendment or Supplement 
thereto); (iii) there shall not have been, since the respective dates as of 
which information is given in the Registration Statement and the Prospectus 
(or any amendment or supplement thereto), except as may otherwise be stated 
in the Registration Statement and Prospectus (or any amendment or supplement 
thereto), any material adverse change in the condition (financial or other), 
business, prospects, properties, net worth or results of operations of the 
Company and the Subsidiaries taken as a whole; (iv) the Company and the 
Subsidiaries shall not have any liabilities or obligations, direct or 
contingent (whether or not in the ordinary course of business), that are 
material to the Company and the Subsidiaries, taken as a whole, other than 
those reflected in the Registration Statement or the Prospectus (or any 
amendment or supplement thereto); and (v) all the representations and 
warranties of the Company contained in this Agreement shall be true and 
correct on and as of the date hereof and on and as of the Closing Date as if 
made on and as of the Closing Date, and you shall have received a 
certificate, dated the Closing Date and signed on behalf of the Company by 
the chief executive officer and the chief financial officer of the Company 
(or such other officers as are acceptable to you), to the effect set forth in 
this Section 8(f) and in Section 8(g) hereof.

(g)  The Company shall not have failed at or prior to the Closing Date to 
have performed or complied with any of its agreements herein contained and 
required to be performed or complied with by it hereunder at or prior to the 
Closing Date.

(h)  Prior to the Closing Date the Shares shall have been listed, subject to
notice of issuance, on the New York Stock Exchange.

(i)  The "lock-up" agreements, each substantially in the form of Annex B 
hereto, between you and Mace Siegel relating to sales and certain other 
dispositions of shares of Common Stock or certain other securities, delivered 
to you on or before the date hereof, shall be in full force and effect on the 
Closing Date.

(j)  The Company shall have furnished or caused to be furnished to you such
further certificates and documents as you shall have requested.

All such opinions, certificates, letters and other documents will be in 
compliance with the provisions hereof only if they are satisfactory in form 
and substance to you and your counsel.

Any certificate or document signed by any officer of the Company and 
delivered to you or to your counsel at the Closing shall be deemed a 
representation and warranty by the Company to the Underwriters as to the 
statements made therein.

                                     - 18 -
<PAGE>

The several obligations of the Underwriters to purchase Additional Shares 
hereunder are subject to the delivery to you on the Option Closing Date of 
such documents as you may reasonably request with respect to the good 
standing of the Company, the due authorization and issuance of the Additional 
Shares and other matters related to the issuance of the Additional Shares.

9.   EXPENSES.  The Company agrees to pay the following costs and expenses 
and all other costs and expenses incident to the performance by it of its 
obligations hereunder: (i) the preparation, printing or reproduction, and 
filing with the Commission of the Registration Statement (including financial 
statements and exhibits thereto), the Prospectus, the Prospectus Supplement 
and each amendment or supplement to any of them; (ii) the printing (or 
reproduction) and delivery (including postage, air freight charges and 
charges for counting and packaging) of such copies of the Registration 
Statement, the Prospectus, the Incorporated Documents, and all amendments or 
supplements to any of them, as may be reasonably requested for use in 
connection with the offering and sale of the Shares; (iii) the preparation, 
printing, authentication, issuance and delivery of certificates for the 
Shares, including any stamp taxes in connection with the original issuance 
and sale of the Shares; (iv) the printing (or reproduction) and delivery of 
this Agreement, the Blue Sky Memorandum and all other agreements or documents 
printed (or reproduced) and delivered in connection with the offering of the 
Shares; (v) the listing of the Shares on the New York Stock Exchange; (vi) 
the registration or qualification of the Shares for offer and sale under the 
securities or Blue Sky laws of the several states as provided in Section 5(g) 
hereof (including the reasonable fees, expenses and disbursements of counsel 
for the Underwriters relating to the preparation, printing or reproduction, 
and delivery of the Blue Sky Memorandum and such registration and 
qualification); (vii) the filing fees in connection with any filings required 
to be made with the National Association of Securities Dealers, Inc.; (viii) 
the transportation and other expenses incurred by or on behalf of Company 
representatives in connection with presentations to prospective purchasers of 
the Shares; and (ix) the fees and expenses of the Company's accountants and 
the fees and expenses of counsel (including local and special counsel) for 
the Company; provided that, except as provided in this Section 9 and Section 
5, you shall pay your own costs and expenses, including the costs and 
expenses of your counsel, any transfer taxes on the Shares which you may sell 
and the expenses of advertising any offering of the Shares made by you.

10.  TERMINATION OF AGREEMENT.  This Agreement shall be subject to 
termination by notice given by you to the Company, if (a) after the execution 
and delivery of this Agreement and prior to the Closing Date (i) trading 
generally shall have been suspended or materially limited on or by, as the 
case may be, any of the New York Stock Exchange, the American Stock Exchange, 
the National Association of Securities Dealers, Inc., the Chicago Board of 
Options Exchange, the Chicago Mercantile Exchange or the Chicago Board of 
Trade, (ii) trading of any securities of the Company shall have been 
suspended on any exchange or in any over-the-counter market, (iii) a general 
moratorium on commercial banking activities in New York shall have been 
declared by either Federal or New York State authorities or (iv) there shall 
have occurred any outbreak or escalation of hostilities or any change in 
financial markets or any calamity or crisis that, in your judgment, is 
material and adverse and (b) in the case of any of the events specified in 
clauses 8(a)(i) through 8(a)(iv), such event, singly or together with any 
other such event, makes it, in your judgment, impracticable to market the 
Shares on the terms and in the manner contemplated in the Prospectus. 

                                     - 19 -
<PAGE>

Notice of such termination may be given to the Company by telegram, telecopy 
or telephone and shall be subsequently confirmed by letter.

11. EFFECTIVENESS; DEFAULTING UNDERWRITERS.  This Agreement shall become 
effective upon the execution and delivery hereof by the parties hereto.

If, on the Closing Date or the Option Closing Date, as the case may be, any 
one or more of the Underwriters shall fail or refuse to purchase Shares that 
it has or they have agreed to purchase hereunder on such date, and the 
aggregate number of Shares which such defaulting Underwriter or Underwriters 
agreed but failed or refused to purchase is not more than one-tenth of the 
aggregate number of the Shares to be purchased on such date, the other 
Underwriters shall be obligated severally in the proportions that the number 
of Firm Shares set forth opposite their respective names in Schedule I bears 
to the aggregate number of Firm Shares set forth opposite the names of all 
such non-defaulting Underwriters, or in such other proportions as you may 
specify, to purchase the Shares which such defaulting Underwriter or 
Underwriters agreed but failed or refused to purchase on such date; PROVIDED 
that in no event shall the number of Shares that any Underwriter has agreed 
to purchase pursuant to this Agreement be increased pursuant to this Section 
11 by an amount in excess of one-ninth of such number of Shares without the 
written consent of such Underwriter.  If, on the Closing Date, any 
Underwriter or Underwriters shall fail or refuse to purchase Firm Shares and 
the aggregate number of Firm Shares with respect to which such default occurs 
is more than one-tenth of the aggregate number of Firm Shares to be 
purchased, and arrangements satisfactory to you and the Company for the 
purchase of such Firm Shares are not made within 36 hours after such default, 
this Agreement shall terminate without liability on the part of any 
non-defaulting Underwriter or the Company.  In any such case either you or 
the Company shall have the right to postpone the Closing Date, but in no 
event for longer than seven days, in order that the required changes, if any, 
in the Registration Statement and in the Prospectus or in any other documents 
or arrangements may be effected.  If, on the Option Closing Date, any 
Underwriter or Underwriters shall fail or refuse to purchase Additional 
Shares and the aggregate number of Additional Shares with respect to which 
such default occurs is more than one-tenth of the aggregate number of 
Additional Shares to be purchased, the non-defaulting Underwriters shall have 
the option to (i) terminate their obligation hereunder to purchase Additional 
Shares or (ii) purchase not less than the number of Additional Shares that 
such non-defaulting Underwriters would have been obligated to purchase in the 
absence of such default.  Any action taken under this paragraph shall not 
relieve any defaulting Underwriter from liability in respect of any default 
of such Underwriter under this Agreement.

If this Agreement shall be terminated by the Underwriters, or any of them, 
because of any failure or refusal on the part of the Company to comply with 
the terms or to fulfill any of the conditions of this Agreement, or if for 
any reason the Company shall be unable to perform its obligations under this 
Agreement, the Company will reimburse the Underwriters or such Underwriters 
as have so terminated this Agreement with respect to themselves, severally, 
for all out-of-pocket expenses (including the fees and disbursements of their 
counsel) reasonably incurred by such Underwriters in connection with this 
Agreement or the offering contemplated hereunder.

                                     - 20 -
<PAGE>

12.  MISCELLANEOUS.  Except as otherwise provided in Sections 5 and 10 
hereof, notice given pursuant to any provision of this Agreement shall be in 
writing and shall be delivered (i) if to the Company, at the office of the 
Company at 401 Wilshire Boulevard, No. 700, Santa Monica, California 90401, 
Attention: General Counsel; or (ii) if to you at 388 Greenwich Street, New 
York, New York 10013, Attention: Manager, Investment Banking Division.

This Agreement has been and is made solely for the benefit of the 
Underwriters, the Company, its directors and officers, and the other 
controlling persons referred to in Section 7 hereof and their respective 
successors and assigns, to the extent provided herein, and no other person 
shall acquire or have any right under or by virtue of this Agreement.  
Neither the term "successor" nor the term "successors and assigns" as used in 
this Agreement shall include a purchaser from the Underwriters of any of the 
Shares in his status as such purchaser.

13.  APPLICABLE LAW; COUNTERPARTS.  This Agreement shall be governed by and 
construed in accordance with the laws of the State of New York applicable to 
contracts made and to be performed within the State of New York.

This Agreement may be signed in various counterparts which together 
constitute one and the same instrument.  If signed in counterparts, this 
Agreement shall not become effective unless at least one counterpart hereof 
shall have been executed and delivered on behalf of each party hereto.


                                     - 21 -
<PAGE>

Please confirm that the foregoing correctly sets forth the agreement between 
the Company and the Underwriters.


Very truly yours,


THE MACERICH COMPANY


By: /s/ Thomas O'Hern
    -------------------------------
Name:  Thomas O'Hern
Title: Senior Vice President and
       Chief Financial Officer


Confirmed as of the date first
above mentioned.

MORGAN STANLEY & CO. INCORPORATED
A.G. EDWARDS & SONS, INC.

Acting severally on behalf 
   of themselves and the 
   several Underwriters named 
   in Schedule I hereto.

By: Morgan Stanley & Co. Incorporated


By: /s/ Stephanie Kaplan-Brody
    -------------------------------
    Name:
    Title:


                                     - 22 -


<PAGE>

                                 EXHIBIT 5.1

December 14, 1998


The Macerich Company
401 Wilshire Boulevard, Suite 700
Santa Monica, California 90401

Re:                                                          SALE OF 1,400,000 
SHARES OF COMMON STOCK OF THE MACERICH COMPANY (THE "COMPANY")

Ladies and Gentlemen:

          We have acted as your special counsel in connection with the issuance
and sale of 1,400,000 shares (the "Shares") of Common Stock, $.01 par value per
share, by the Company pursuant to an Underwriting Agreement dated December 9,
1998 (the "Underwriting Agreement") among Morgan Stanley & Co. Incorporated and
A.G. Edwards & Sons, Inc. and the Company.  The Shares are registered pursuant
to the Registration Statement on Form S-3, File No. 333-21157, as amended, (the
"Registration Statement"), filed by the Company with the Securities and Exchange
Commission in connection with the registration of up to $500,000,000 aggregate
offering price of securities.  We are familiar with the proceedings heretofore
taken by the Company in connection with the authorization, registration,
issuance and sale of the Shares.

          On the basis of the foregoing and in reliance thereon and our
consideration of such other matters of fact and questions of law as we have
deemed relevant in the circumstances, we are of the opinion that, subject to the
assumptions and limitations set forth herein, upon payment for and delivery of
the Shares in accordance with the terms of the Underwriting Agreement, such
Shares will be validly issued, fully paid and nonassessable.

<PAGE>

          The law covered by this opinion is limited to the present Maryland
General Corporation Law.  We express no opinion as to the laws of any other
jurisdiction and no opinion regarding statutes, administrative decisions, rules
or regulations of any county, municipality or special political subdivision or
other local authority.

          We have, with your approval, assumed that the signatures on all
documents examined by us are genuine, that all items submitted as originals are
authentic, and that all items submitted as copies conform to the originals,
assumptions which we have not independently verified.

          We consent to the filing of this opinion as an exhibit to the
Company's Current Report on Form 8-K, event date December 9, 1998, and the use
to the name of our firm therein.

                                       Respectfully submitted, 
                                       /s/ O'Melveny & Myers LLP




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission